ANRIA
HZNP

American National Registered Investment Advisor’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

American National Registered Investment Advisor’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-18,315
Closed -$217K – 254
2017
Q2 		$217K Hold
18,315
– – 0.09% 240
2017
Q1 		$271K Hold
18,315
– – 0.12% 228
2016
Q4 		$296K Hold
18,315
– – 0.13% 212
2016
Q3 		$332K Hold
18,315
– – 0.15% 212
2016
Q2 		$302K Hold
18,315
– – 0.14% 215
2016
Q1 		$303K Hold
18,315
– – 0.15% 207
2015
Q4 		$397K Buy
+18,315
New +$357K 0.19% 176

Other funds holding HZNP

SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

American National Registered Investment Advisor's HZNP Position: Q3 2017 in Review

American National Registered Investment Advisor sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2017, closing a stake of 18,315 shares — an estimated $217K sold.

American National Registered Investment Advisor first reported a position in HZNP in Q4 2015 and held it in 7 quarters. The position peaked at $397K in Q4 2015. 181 funds tracked by Wall St. Rank hold HZNP as of Q3 2017.

  • American National Registered Investment Advisor reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2017 after selling out during the quarter.
  • American National Registered Investment Advisor sold 18,315 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2017, an estimated $217K.
  • American National Registered Investment Advisor first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 7 quarters.
  • American National Registered Investment Advisor's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $397K in Q4 2015.
  • 181 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2017.

Based on American National Registered Investment Advisor's 13F filing for Q3 2017, filed 13 Nov 2017.